Deep Creek Pharma Pursuing FDA Approval for Revolutionary Treatment A pharmaceutical development startup born from local cancer research is getting a boost in its next phase of growth through Greater Winston-Salem Inc.’s BioNest Grant. Deep Creek Pharma is developing a next-generation chemotherapy that could replace the current standard of care for many solid tumor indications.… Read More »
Category: Featured
Local Company Developing Nex-Gen Chemotherapy Receives BioNest Grant for Next Phase of Growth
Senior Academy Behind the Scenes
Forsyth Tech partnered with Greater Winston-Salem Inc. (GWSI) to support Senior Academy, welcoming 82 high school seniors from six Forsyth County high schools for a day of career exploration and college connection. The students participate in the year-long Senior Academy mentoring program, meeting with their mentor one-on-one throughout the school year to help guide and… Read More »
GWSI Recognized for Communications Excellence
Greater Winston-Salem Inc. is excited to announce that we have been awarded a Communications Excellence Award for our Greater Winston-Salem: Industry and Community Insights publication by the Carolinas Association of Chamber of Commerce Executives (CACCE). CACCE recognizes outstanding communications efforts by chambers of commerce across North Carolina and South Carolina, highlighting innovative strategies, compelling storytelling,… Read More »
Community Feedback Requested for Imagine Winston-Salem Plan
Community Invited to Shape Plan for Downtown The community is invited to lend their ideas and feedback as we create a strategic vision for Winston-Salem’s future, together. The time has come for public input in the strategic action planning process for the Imagine Winston-Salem plan. A new survey asks residents, business owners, workers, and visitors to… Read More »
Winston-Salem Partner’s Roundtable Fund Announces New Investments
Local angel fund has made new investments in three early-stage companies The Winston-Salem Partners Roundtable (WSPR) Fund is proud to support the growth of three local startups with new rounds of funding for the following companies: KeraVet Bio is the maker of KeraVet® Gel, a revolutionary new prescription hydrogel developed with the human-animal bond… Read More »
Korean Biopharmaceutical Company, CorestemChemon, Selects Winston-Salem’s Wake Forest Institute for Regenerative Medicine (WFIRM) for US Base of Operations
Company Receives BioNest Grant to Support Entry into US Market CorestemChemon, a biopharmaceutical company headquartered in South Korea, has selected Winston-Salem as the location for its U.S. base of operations. The company will be located within the Regenerative Medicine (RegenMed) Engine’s Innovation Accelerator, based in the Innovation Quarter. With about 350 employees worldwide, CorestemChemon is… Read More »